Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. Sudbø, J; Lee, JJ; Lippman, SM; Mork, J; Sagen, S; Flatner, N; Ristimaki, A; Sudbo, A; Mao, L; Zhou, X; Kildal, W; Evensen, JF; Reith, A; Dannenberg, AJ .

Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling.. Sudbø, J; Samuelsson, R; Risberg, B; Heistein, S; Nyhus, C; Samuelsson, M; Puntervold, R; Sigstad, E; Davidson, B; Reith, A; Berner, A. .

The influence of resection and aneuploidy on mortality in oral leukoplakia. Sudbø, J.; Lippman, S.M.; Lee, JJ; Mao L; Kildal, W; Sudbø, A; Sagen, S; Bryne, M; El-Naggar, A; Risberg, B; Evensen, JF; Reith, A. .

Nuclear translocation of LIM kinase mediates Rho-Rho kinase regulation of cyclin D1 expression.. Roovers, K.; Klein, E.A.; Castagnino, P.; Assoian, R.K. .

DNA Content as a Prognostic Marker in Patients with Oral Leukoplakia. Sudbø, J; Kildal, W; Risberg, B; Koppang, HS; Danielsen, HE; Reith, A .

Timing of cyclin D1 expression within G1 phase is controlled by Rho. Welsh, C.F.; Roovers, K.; Villanueva, J.; Liu, Y.; Schwartz, M.A.; Assoian, R.K. .